Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...

Ulta Beauty (NASDAQ:ULTA – Get Free Report) had its price target lowered by BMO Capital Markets from $467.00 to $404.00 in a ...

Charles Schwab Investment Management Inc. raised its position in DXC Technology (NYSE:DXC – Free Report) by 3.5% in the 4th ...